27-Mar-2025 3:01 PM CST - Business Wire Harrow Announces Fourth-Quarter and Year-End 2024 Audited Financial Results $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the fourth quarter and year ended December 31, 2024. The Company also posted its fourth quarter Letter to Stockholders and corporate presentation to the Investors section of its website, harrow.com. The Company encourages all Harrow stockholders to review these documents, which provide additional details concerning the historical quarterly period and future
27-Mar-2025 9:45 AM CST - Business Wire Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025 $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its fourth quarter and audited financial results for the year ended December 31, 2024, on Thursday, March 27, 2025, after the market close. The Company will also post its fourth quarter Letter to Stockholders to the Investors section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Fri
17-Mar-2025 3:01 PM CST - Business Wire Harrow Provides Fourth Quarter and Year-End 2024 Unaudited Preliminary Financial Results and 2025 Revenue Guidance $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced unaudited preliminary financial results for the fourth quarter and year ended December 31, 2024, as well as revenue guidance for 2025. Although Harrow was initially scheduled to release its audited financial results today, the Companys new independent auditor requires additional time to audit Harrows financial presentation. As a result, Harrow is delaying its earn
3-Mar-2025 6:15 AM CST - Business Wire Harrow to Report Fourth Quarter and Year-End 2024 Financial Results After Market Close on March 17, 2025 $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2024, on Monday, March 17, 2025, after the market close. The Company will also post its fourth quarter Letter to Stockholders to the Investors section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Tuesday, Marc
13-Nov-2024 3:34 PM CST - Business Wire Harrow Announces Third Quarter 2024 Financial Results $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the third quarter and nine months ended September 30, 2024. The Company also posted its third quarter Letter to Stockholders and corporate presentation to the Investors section of its website, harrow.com. The Company encourages all Harrow stockholders to review these documents, which provide additional details concerning the historical quarterly period and f
31-Oct-2024 6:00 AM CST - Business Wire Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024 $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its financial results for the third quarter ended September 30, 2024, on Wednesday, November 13, 2024, after the market close. The Company will also post its third quarter Letter to Stockholders to the Investors section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Thursday, Novembe
27-Mar-2025 3:01 PM CST - Business Wire Harrow Announces Fourth-Quarter and Year-End 2024 Audited Financial Results $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the fourth quarter and year ended December 31, 2024. The Company also posted its fourth quarter Letter to Stockholders and corporate presentation to the Investors section of its website, harrow.com. The Company encourages all Harrow stockholders to review these documents, which provide additional details concerning the historical quarterly period and future
27-Mar-2025 9:45 AM CST - Business Wire Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025 $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its fourth quarter and audited financial results for the year ended December 31, 2024, on Thursday, March 27, 2025, after the market close. The Company will also post its fourth quarter Letter to Stockholders to the Investors section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Fri
17-Mar-2025 3:01 PM CST - Business Wire Harrow Provides Fourth Quarter and Year-End 2024 Unaudited Preliminary Financial Results and 2025 Revenue Guidance $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced unaudited preliminary financial results for the fourth quarter and year ended December 31, 2024, as well as revenue guidance for 2025. Although Harrow was initially scheduled to release its audited financial results today, the Companys new independent auditor requires additional time to audit Harrows financial presentation. As a result, Harrow is delaying its earn
3-Mar-2025 6:15 AM CST - Business Wire Harrow to Report Fourth Quarter and Year-End 2024 Financial Results After Market Close on March 17, 2025 $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2024, on Monday, March 17, 2025, after the market close. The Company will also post its fourth quarter Letter to Stockholders to the Investors section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Tuesday, Marc
13-Nov-2024 3:34 PM CST - Business Wire Harrow Announces Third Quarter 2024 Financial Results $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the third quarter and nine months ended September 30, 2024. The Company also posted its third quarter Letter to Stockholders and corporate presentation to the Investors section of its website, harrow.com. The Company encourages all Harrow stockholders to review these documents, which provide additional details concerning the historical quarterly period and f
31-Oct-2024 6:00 AM CST - Business Wire Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024 $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its financial results for the third quarter ended September 30, 2024, on Wednesday, November 13, 2024, after the market close. The Company will also post its third quarter Letter to Stockholders to the Investors section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Thursday, Novembe
